BioAgilytix

If you're searching for the "difference between pharmacokinetics and pharmacodynamics (PK/PD)" or wondering "what is PK vs PD in drug development," this article provides a clear, detailed explanation to help you understand these essential concepts in phar

In March 2025, a landmark moment in gene therapy quietly reshaped what's possible in the treatment of ultra-rare diseases. A team at Children's Hospital of Philadelphia (CHOP) successfully administered a personalized CRISPR-based therapy to a young patien

BioAgilytix officials say the company's expansion strengthens its ability to support biopharma partners at every stage of development.

Demonstrating equivalence in a landscape of evolving technologies and regulations Riding a wave of blockbuster molecule patent expirations, the global biosimilar market grew to nearly $18 billion in 2020. With a total of 26 blockbuster drugs coming off pa

An Introduction to CMC CMC (chemistry, manufacturing, and controls) is a term used when drug developers define their investigative drug substance, establish manufacturing methods for that drug, and develop a roadmap for controlling the quality and stabili

Introduction to Large Molecules Therapeutics are an ever-evolving landscape of modalities which range in complexity but can be grouped into two broad categories: small molecules and large molecules. Small molecule therapeutics have historically dominated

Basic Principles of LC/MS Methods Liquid Chromatography-Mass Spectrometry (LC/MS) is a technique that involves the physical separation of target analytes followed by their mass-based detection. The key elements of these analytical systems include an autos

The third and final blog in our cell and gene therapy series will focus on PCR as a bioanalytical tool for gene and cell therapy. Be sure to read our first blog on bioanalytical support for gene therapy programs and the second blog on the safety and effic

An Overview of Cell Therapy: As we continue our blog series on cell and gene therapy, we will now dive into cell therapy programs. If you missed the first blog "Bioanalytical Support for Gene Therapy Programs," you can find it here. Cell Therapy or Adopti

An Introduction to Gene Therapy: As early as the 1970's, the term "gene therapy" was used for the treatment of genetic disorders at the DNA level to replace the defective or missing proteins driving disease. By introducing functional gene copies to patien